
Quarterly report 2025-Q3
added 11-19-2025
Vivos Therapeutics Market Cap 2011-2026 | VVOS
As of March 27, 2026 Vivos Therapeutics has a market cap of $ 5.72 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Vivos Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.3 M | 5.89 M | 322 K | 70.9 B | 116 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 70.9 B | 322 K | 14.2 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | ||
|
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M | ||
|
Sintx Technologies
SINT
|
6.91 M | $ 2.3 | -4.96 % | $ 6.38 M | ||
|
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | ||
|
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | ||
|
Align Technology
ALGN
|
13.9 B | $ 166.05 | -6.36 % | $ 12.4 B | ||
|
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | ||
|
Sensus Healthcare
SRTS
|
72.3 M | $ 3.79 | -5.61 % | $ 61.9 M | ||
|
Stryker Corporation
SYK
|
147 B | $ 328.87 | -1.15 % | $ 126 B | ||
|
Alphatec Holdings
ATEC
|
2.07 B | $ 10.97 | -4.78 % | $ 1.65 B | ||
|
Tactile Systems Technology
TCMD
|
640 M | $ 26.49 | -1.08 % | $ 606 M | ||
|
TELA Bio
TELA
|
32.4 M | $ 0.67 | -10.47 % | $ 31.5 M | ||
|
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | ||
|
Accuray Incorporated
ARAY
|
160 M | $ 0.38 | 1.99 % | $ 39.1 M | ||
|
Abbott Laboratories
ABT
|
196 B | $ 104.91 | 0.33 % | $ 183 B | ||
|
Tandem Diabetes Care
TNDM
|
1.26 B | $ 21.24 | -8.92 % | $ 1.44 B | ||
|
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | ||
|
Second Sight Medical Products
EYES
|
225 M | - | -0.97 % | $ 54.4 M | ||
|
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | ||
|
Boston Scientific Corporation
BSX
|
113 B | $ 69.46 | -1.01 % | $ 103 B | ||
|
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | ||
|
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | ||
|
CONMED Corporation
CNMD
|
1.32 B | $ 35.4 | -3.38 % | $ 1.1 B | ||
|
Establishment Labs Holdings
ESTA
|
2.31 B | $ 56.7 | -5.36 % | $ 1.68 B | ||
|
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B | ||
|
NanoVibronix
NAOV
|
920 K | - | - | $ 1.08 M | ||
|
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
677 M | - | - | $ 111 M | ||
|
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | ||
|
Viemed Healthcare
VMD
|
352 M | $ 9.27 | 0.54 % | $ 361 M | ||
|
Cytosorbents Corporation
CTSO
|
54.4 M | $ 0.61 | 1.65 % | $ 33.2 M | ||
|
Aethlon Medical
AEMD
|
3.03 M | $ 2.14 | -5.73 % | $ 3.34 M | ||
|
Varex Imaging Corporation
VREX
|
502 M | $ 10.82 | 0.32 % | $ 448 M | ||
|
Edwards Lifesciences Corporation
EW
|
48.8 B | $ 79.47 | -3.2 % | $ 46.5 B | ||
|
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | ||
|
Beyond Air
XAIR
|
15.6 M | $ 0.72 | 4.06 % | $ 48.7 M | ||
|
Xtant Medical Holdings
XTNT
|
57.5 M | $ 0.55 | -2.12 % | $ 73.5 M | ||
|
Inogen
INGN
|
160 M | $ 6.29 | -3.31 % | $ 167 M | ||
|
Zimmer Biomet Holdings
ZBH
|
21.8 B | $ 88.46 | -0.77 % | $ 18 B | ||
|
AdaptHealth Corp.
AHCO
|
1.2 B | $ 11.16 | -2.19 % | $ 1.51 B | ||
|
OrthoPediatrics Corp.
KIDS
|
437 M | $ 15.81 | -3.3 % | $ 371 M | ||
|
Invacare Corporation
IVC
|
24.1 M | - | - | $ 24.7 M | ||
|
Ra Medical Systems
RMED
|
1.49 M | - | 10.0 % | $ 610 K |